1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Susana Benlloch is the recipient of a research contract from the Spanish Ministry of Health.
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion†
Article first published online: 18 SEP 2006
DOI: 10.1002/cncr.22190
Copyright © 2006 American Cancer Society
Additional Information
How to Cite
Benlloch, S., Galbis-Caravajal, J. M., Martín, C., Sanchez-Paya, J., Rodríguez-Paniagua, J. M., Romero, S., Mafe, J. J. and Massutí, B. (2006), Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer, 107: 1859–1865. doi: 10.1002/cncr.22190
- †
Presented in part at the International Association for the Study of Lung Cancer 11th World Conference on Lung Cancer, Barcelona, Spain, July 3–6, 2005.
Publication History
- Issue published online: 3 OCT 2006
- Article first published online: 18 SEP 2006
- Manuscript Accepted: 6 JUL 2006
- Manuscript Revised: 14 JUN 2006
- Manuscript Received: 10 FEB 2006
Funded by
- Spanish Ministry of Health. Grant Number: (FIS 01/3080)
- Spanish Society of Medical Oncology
REFERENCES
- 1, , , et al. Primary intrathoracic malignant effusions: a descriptive study. Chest. 2001; 120: 50–54.
- 2. Malignant pleural effusions. In: LightRW, editor. Pleural Diseases. 3rd ed. Baltimore: Williams & Williams; 1995: 94–116.
- 3, , , et al. Evaluation of seven tumors markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer. 1999; 81: 1059–1065.
- 4, . Malignant pleural and pericardical effusions. In: SelkeF, SwansonS, Del NidoPJ, editors. Sabiston & Spencer's Surgery of the Chest. 7th ed. Philadelphia: 2005: 450.
- 5. DNA methylation errors and cancer. Cancer Res. 1996; 56: 2463–2467.
- 6, . DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000; 16: 168–174.
- 7, , , , . Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998; 72: 141–196.
- 8. The DNA methylation paradox. Trends Genet. 1999; 15: 34–37.
- 9, , , , , . Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 2002; 62: 351–355.
- 10, , , et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002; 62: 2370–2377.
- 11, , , et al. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat Med. 1997; 3: 686–690.
- 12, , , , , . Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000; 25: 315–319.
- 13. Cancer cell cycles. Science. 1996; 274: 1672–1677.
- 14, , , et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumour suppressor gene. Oncogene. 1997; 15: 403–407.
- 15, , , . DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene. 2002; 21: 5450–5461.
- 16, , . Aberrant methylation of gene promoters in cancer—concepts, misconcepts, and promise. J Natl Cancer Inst. 2000; 92: 1460–1461.
- 17, , , et al. Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Lett. 2003; 193: 207–216.
- 18, , , et al. 14-3-3Sigma methylation in pretreatment serum circulating DNA of cisplatinum-plus-gemcitabine-treated advanced non-small-cell-lung cancer patients predicts survival: The Spanish Lung Cancer Group. J Clin Oncol. 2005; 23: 9105–9112.
- 19, , , et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res. 2004; 10: 2284–2288.
- 20, , , et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60: 5954–5958.
- 21, , , et al. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg. 2005; 80: 1241–1247.
- 22, , , , . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996; 93: 9821–9826.
- 23, , , et al. Annual report to the nation on the status of cancer 1973–1996. J Natl Cancer Inst. 1999; 91: 675–690.
- 24, , , et al. Tumor specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol. 2004; 22: 2363–2370.
- 25, , , , , . Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res. 2004; 10: 2401–2406.
- 26, , , , , . Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci. 2003; 94: 589–592.Direct Link:
- 27, , , et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res. 2004; 10: 6126–6133.
- 28, , , , , . Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999; 59: 67–70.
- 29, , , et al. CEA, CA 15–3 and CYFRA 21–1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J. 1996; 9: 17–23.
- 30, , , et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000; 28: e32.